TRIVASTAL

This brand name is authorized in France, Malta, Singapore, Tunisia, Turkey

Active ingredients

The drug TRIVASTAL contains one active pharmaceutical ingredient (API):

1 Piribedil
UNII DO22K1PRDJ - PIRIBEDIL

Piribedil is a dopaminergic agonist (stimulates dopamine receptors and the cerebral dopaminergic pathways).

Read about Piribedil

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
TRIVASTAL Sustained release coated tablet Web Search MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N04BC08 Piribedil N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de données publique des médicaments Identifier(s): 61598530, 62551633
Country: MT Medicines Authority Identifier(s): MA066/01101
Country: SG Health Sciences Authority Identifier(s): 09947P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 6353091
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699552140122

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.